Blog
Dick's Sporting Goods (DKS) is a Top-Ranked Value Stock: Should You Buy?
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Why Radian (RDN) is a Top Value Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Is Everus Construction Group, Inc. (ECG) Outperforming Other Construction Stocks This Year?
Investors interested in Construction stocks should always be looking to find the best-performing companies in the group. Is Everus Construction Group, Inc. (ECG) one of those stocks right now? By
Why DocuSign (DOCU) is a Top Value Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Is United Natural Foods (UNFI) a Great Value Stock Right Now?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always
Is Intrepid Potash (IPI) Stock Outpacing Its Basic Materials Peers This Year?
Investors interested in Basic Materials stocks should always be looking to find the best-performing companies in the group. Is Intrepid Potash (IPI) one of those stocks right now? Let's take a
Why Commercial Metals (CMC) is a Top Value Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Are Medical Stocks Lagging BillionToOne, Inc. (BLLN) This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has BillionToOne (BLLN) been one of those stocks this year? A
Are Consumer Discretionary Stocks Lagging Central Garden & Pet (CENTA) This Year?
The Consumer Discretionary group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Central Garden (CENTA) is a stock that can
Here's Why Walt Disney (DIS) is a Strong Value Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Should Value Investors Buy Arrow Electronics (ARW) Stock?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Is Progress Software (PRGS) a Great Value Stock Right Now?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
Should Value Investors Buy Eastman Chemical (EMN) Stock?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Is Cummins (CMI) Outperforming Other Auto-Tires-Trucks Stocks This Year?
For those looking to find strong Auto-Tires-Trucks stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Cummins (CMI) been one of those stocks this
Why Capri Holdings (CPRI) is a Top Value Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service
Here's Why Astrazeneca (AZN) is a Strong Value Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Should Value Investors Buy Banco Bradesco (BBD) Stock?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
COHU Stock Outlook Hinges on AI Growth and Profit Recovery
Cohu, Inc. COHU is drawing more attention as AI infrastructure spending raises the need for advanced semiconductor test, inspection and thermal-control equipment.
The investment case now rests on
VSXY Shows How Full-Price Retail and Gen Z Demand Are Evolving
Victoria’s Secret & Co. VSXY is turning into a useful read-through for apparel retail. Its latest results show how product acceptance, brand relevance and channel execution can matter even when
Can AMKR's 2.5D Packaging Pipeline Drive Long-Term Growth?
Amkor Technology's AMKR expanding 2.5D packaging pipeline is emerging as a key growth lever as AI and high-performance computing customers shift toward chiplet-based architectures. As semiconductor
Worthington Steel, Inc. (WS) Loses 23.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Worthington Steel, Inc. (WS) has been beaten down lately with too much selling pressure. While the stock has lost 23.8% over the past four weeks, there is light at the end of the tunnel as it is now
Liberty Energy (LBRT) Loses 21.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Liberty Energy (LBRT) has been on a downward spiral lately with significant selling pressure. After declining 21.7% over the past four weeks, the stock looks well positioned for a trend reversal as
TXN Stock Soars 52% in Three Months: Is There More Upside Ahead?
Texas Instruments Incorporated TXN shares have rallied 51.9% over the past three months, making the company one of the biggest winners in the semiconductor space. The stock has comfortably
CPRX's Agamree Shows Potential Beyond DMD After Positive Phase I Data
Catalyst Pharmaceuticals CPRX has reported positive top-line results from an early-stage study evaluating Agamree (vamorolone) to explore additional indications beyond its currently approved use in



